Oak Hill-backed Petauri acquires medical communications agency Emotive
Emotive, a global medical communications agency founded in 2013, joins Petauri Advance, Petauri's medical communications collective.
Petauri, a pharmaceutical services platform based in Nashville, Tennessee, has acquired Emotive, a global medical communications agency, according to a release dated November 10, 2026. The deal adds Emotive to Petauri Advance, the platform's medical communications collective, and expands its global reach. Financial terms were not disclosed.
Emotive was founded in 2013 and provides strategic, scientific and creative communications, with particular depth in neuroscience and immunology and experience in oncology and rare disease. It will join Petauri Advance's existing agencies, including DRIVE, PROPEL, MOMENTUM, BluPrint Oncology, Verascity Science and Cogency. Petauri was founded by CEO Dan Renick in partnership with Oak Hill Capital, which will invest more than $250 million of equity from its OHCP VI fund in the platform.
Chris Edmonds, Emotive's founder and CEO, will serve as Executive Advisor. Lisa Hefner, Group President of Petauri Advance, said the combination brings specialized knowledge across geographies, therapeutic areas and disciplines.
Deal facts
- Target
- Emotive
- Business
- Global medical communications agency founded in 2013 with depth in neuroscience and immunology
- Acquirer
- Petauri
- Backed by
- Oak Hill Capital
- Deal type
- Add-on
- Status
- Completed
- Announced
- Tuesday, November 10, 2026
Sources
- PR NewswireNov 10, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.